Journal Report

INFLAMMATORY BOWEL DISEASES

Download PDF
Journal Information
Journal Title
INFLAMMATORY BOWEL DISEASES
Publisher
OXFORD UNIV PRESS INC
ISSN
1078-0998
E-ISSN
1536-4844
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Epstein–Barr virus and inflammatory bowel disease: a systematic review of its clinical significance and potential pathogenic role
Maria Manuela Estevinho, Hyder Said, Anubhab Nandy et al.
2026-11-10
DOI: 10.1093/ibd/izag230
Impact of in vitro fertilization on disease activity and pregnancy outcomes in women with inflammatory bowel disease
Rohit Khanna, Nicole M Garcia, Cynthia Fenton et al.
2026-11-10
DOI: 10.1093/ibd/izag223
Comparative effectiveness of infliximab and tofacitinib in advanced therapy-naive and -exposed patients with ulcerative colitis: a multicenter real-world study
Noboru Mizuta, Naohiko Kinoshita, Kazuki Kakimoto et al.
2026-11-10
DOI: 10.1093/ibd/izag248
Cellular therapies and immune reprogramming in inflammatory bowel disease: lessons learned and the promise of CAR T-cell therapy
Tommaso L Parigi, Bianca N Islam, Theresa T Pizarro et al.
2026-11-10
DOI: 10.1093/ibd/izag233
Interpretable machine learning applied to high-dimensional salivary proteomics in pediatric inflammatory bowel diseases
Brittany T Rupp, Joaquin Reyna, Ally Giunta et al.
2026-11-9
DOI: 10.1093/ibd/izag181
Peripheral T- and B-cell immune signatures associated with response to vedolizumab in ulcerative colitis
Shunsuke Horitani, Anna Horitani, Christopher J Tyler et al.
2026-11-6
DOI: 10.1093/ibd/izag242
Response to Letter “Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?”
Dhamyanthi Thangarajah, Karyn Chappell, Anyavathi Helena Burtt et al.
2026-11-6
DOI: 10.1093/ibd/izag232
Effects of upadacitinib on lipid profiles and their relationship with inflammation in patients with inflammatory bowel disease: a real-world longitudinal cohort study
Shengduo He, Wei Zhang, Yuling Tian et al.
2026-11-5
DOI: 10.1093/ibd/izag241
The application of an artificial intelligence–enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot study
Alvin T George, Alexandra R McDermott, Alyse R Bedell et al.
2026-11-5
DOI: 10.1093/ibd/izag208
Performance of an infliximab precision-guided dosing tool from a capillary blood–based self-collection device in inflammatory bowel disease patients
Cindy C Y Law, Arafa Djalal, Mason Hopkins et al.
2026-11-5
DOI: 10.1093/ibd/izag214
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 12, 2026 11:06